Please wait while the formulary information is being retrieved.
ANBESOL (BENZOCAINE)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
- Oral Pain Relief Mucosal Gel
- Oral Anesthetic Mucosal Gel
- Oral Analgesic Mucosal Gel
- Mouth Pain Oral Mucosal Liquid
- Intense Toothache Pain Relief Mucosal Gel
- Hurricaine Oral Mucosal Liquid
- Hurricaine Mucosal Gel
- Benz-o-sthetic Mucosal Gel
- Anesthetic Oral Gel
- Anbesol Cold Sore Topical Ointment
- Anbesol (benzocaine) Oral Mucosal Liquid
- Anbesol (benzocaine) Mucosal Gel
- Anbesol (benzocaine) Maximum Strength Mucosal Gel
20 % mucosal gel
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % oral mucosal liquid
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % oral mucosal liquid
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 % mucosal gel
- Dosage information is not available
20 %
- Dosage information is not available
Cold Sore 20 %-3 %-1 %-64.9 % topical ointment
- Dosage information is not available
(benzocaine) 10 % oral mucosal liquid
- Dosage information is not available
(benzocaine) 20 % oral mucosal liquid
- Dosage information is not available
(benzocaine) 10 % mucosal gel
- Dosage information is not available
(benzocaine) Maximum Strength 20 % mucosal gel
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Large open wound
- Methemoglobinemia
Contraindicated
- Cardiac arrhythmia
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from PK and g6PD deficiencies
- NADH methemoglobin reductase deficiency
- Systemic mastocytosis
Severe
Moderate
- Respiratory depression
- Seizure disorder
ANBESOL (BENZOCAINE)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
- None
- None
More Frequent
Severe
Less Severe
- Angioedema
- Dermatitis due to topical drug
- Erythema
- Pruritus of skin
- Skin rash
- Stinging of skin
- Urticaria
- Contact dermatitis
- Erythema
- Mouth irritation
- Pruritus of skin
- Skin rash
- Urticaria
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory insufficiency
- Anaphylaxis
- Bradycardia
- Cardiac arrhythmia
- CNS toxicity
- Cyanosis
- Drowsy
- Eyelid edema
- Headache disorder
- Hypotension
- Methemoglobinemia
- Respiratory depression
- Seizure disorder
- Tremor
- Unconsciousness
Less Severe
- Acute confusion
- Apprehension
- Blurred vision
- Dizziness
- Edema
- Euphoria
- Nervousness
- Sensation of cold
- Sensation of warmth
- Tinnitus
- Twitching
- Vomiting
Contraindicated
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
- 1 Day – 2 Years
- 1 Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
Severe Precaution
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Consult clinician prior to use.
Increased risk for developing methemoglobinemia. Consult clinician for use age < 2 years.
- 2 Years – 6 Years
- Increased risk for developing methemoglobinemia. Consult clinician prior to use.
- 1 Day – 2 Years
- Increased risk for developing methemoglobinemia. Consult clinician prior to use.
Benzocaine (Top,Rectal,Misc)
Increased risk for developing methemoglobinemia. Consult clinician prior to use.
Increased risk for developing methemoglobinemia. Consult clinician for use age < 2 years.
- 2 Years – 6 Years
- Increased risk for developing methemoglobinemia. Consult clinician for use age < 2 years.
- 1 Day – 2 Years
- Increased risk for developing methemoglobinemia. Consult clinician for use age < 2 years.
Management or Monitoring Precaution
None
Camphor(topical)
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Benzocaine
Reports of infant methemoglobinemia after ingestion of topical benzocaine
Insufficient data available; likely compatible per briggs.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | No adverse effect | Reports of infant methemoglobinemia after ingestion of topical benzocaine |
Camphor (top)
Reports of infant methemoglobinemia after ingestion of topical benzocaine
Insufficient data available; likely compatible per briggs.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; likely compatible per briggs. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Mouth irritation | |
| K13.79 | Other lesions of oral mucosa |
| 0-9 | A-Z |
|---|---|
| K13.79 | Other lesions of oral mucosa |
Formulary Reference Tool